Latest market price
3.38
-0.28-7.65%
OverviewShort InterestFilings
SPRYQT27ARS Pharmaceuticals, Inc.·NASDAQ
3.38-7.65%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 05, 20264Statement of changes in beneficial ownership
Sep 02, 20264Statement of changes in beneficial ownership
Aug 17, 20263Initial statement of beneficial ownership
Aug 13, 202610-QQuarterly report
Aug 13, 20268-KCurrent report
Jul 27, 2026SC 13GBeneficial ownership statement (passive)
Jul 17, 20268-KCurrent report
Jul 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 07, 20268-KCurrent report
Jul 02, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 26, 20264Statement of changes in beneficial ownership
Jun 25, 20268-KCurrent report
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 01, 20263Initial statement of beneficial ownership
May 15, 202610-QQuarterly report
May 15, 20268-KCurrent report
#1 / 25 of 280
Page
▼
/ 12